Data from this study, together with results from the Phase 1a/1b ulcerative colitis (UC) program, are expected to support Phase 2 Investigational New Drug (IND) submissions to the U.S. Food and Drug ...

Saudi Arabia - Jeddah Jeddah hosted recently the 5th Immunology EXPO Forum 2025, with the participation of a group of ...

Risk for venous thromboembolism (VTE) after an operation for colorectal cancer (CRC) is higher among patients with inflammatory bowel disease (IBD), according to results of a population-based cohort ...

In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), presents a significant therapeutic challenge due to its chronic ...

Chronic liver disease can lead to a condition called Overt Hepatic Encephalopathy. Dr Salhab discusses the causes, symptoms and treatment options.

US FDA approves expanded paediatric indications for Celltrion’s Yuflyma and unbranded adalimumab-aaty: Incheon, South Korea Monday, October 20, 2025, 17:00 Hrs [IST] Celltrion, ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.

Inflammatory Bowel Disease (IBD) affects nearly 500,000 people in the UK. The 'A Chronic Cost' campaign advocates for free ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...